sprite-preloader
Anzeige
Mehr »
Dienstag, 17.10.2017 Börsentäglich über 12.000 News von 569 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Passende Knock-Outs zu Ihrer Suchanfrage (Anzeige)
Erweiterte
Suche
lynx
Ad hoc-Mitteilungen

Aktuelle News von FiercePharma

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
MoAllergan loses Restasis patent protections in court decision
MoReckitt's still keen on a Pfizer OTC buy. But can it afford one?
MoTop drug distributors face scrutiny on opioid sales
MoFDA eyes CV, eye data as Novo's semaglutide nears panel vote
MoShire activists angle for a breakup to revive struggling shares
MoJudge urged to call Allergan's tribal patent deal a 'sham'
MoAlexa-enabled diabetes coach snags Merck prize
MoJ&J's Stelara breaks into adolescent psoriasis market
MoAdvice for pharma in payer marketing? Ramp up digital
MoJanssen R&D videos tackle treatment-resistant depression
MoMerck to high-risk military veterans: Get a hep C education
FrEbola vaccines from GSK, Merck elicit yearlong response
FrAs Taltz growth stalls, Lilly looks ahead to PsA expansion
FrRoche's loss of 'Cabilly patents' will cost it more than $600M
FrIn U-turn, NICE backs BMS' Opdivo in head and neck cancer
FrFiercePharmaAsia-China drug policy, Biocon, C-Bridge
FrAllergan, InnoPharma agree to terms on Restasis generic
FrDid Avanir overmarket its brain drug to the elderly?
DoNovartis puts $14B Roche stake back in its pocket
DoWith generics looming, Pfizer wins FDA nod for longer-acting Lyrica
DoNICE expands Bayer's Stivarga prospects with move from CDF
DoDrug shortages reported as Puerto Rico hurricane damage lingers
DoSanofi builds on its lead in flu vaccines with $200M investment
MiGottlieb says he is 'most effective' at FDA
MiGet ready for more pricing pressure, thanks to California